CME Group Inc. — 8.35/10

BUY
NASDAQ: CME  | Dominant/monopolistic US derivatives exchange. >50% share in interest rates, equity index, energy (WTI), agriculture, metals. One of the sole players controlling >70% of US exchange-listed derivatives. Record ADV 36.2M contracts in Q1'26. Revenue +14.5% YoY. ~66% FCF margin. CEO Terry Duffy since 2006 with ~83% promise hit rate. All quality gates PASS.
Q1'26 Revenue
$1.88B
src/165058919 | +14.5% YoY | Record ADV
FCF Margin
~66%
Strongly positive & growing | +12.3% YoY
Market Position
Monopolistic
>50% share in core products | Oligopoly PASS
CEO Tenure
20+ years
Terry Duffy since 2006 | Exceptional stability
Company overview

CME Group is the dominant US derivatives exchange, operating marketplaces across six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals, and foreign exchange. The company holds >50% share in each core product category and controls >70% of US exchange-listed derivatives volume. Q1 2026 delivered record average daily volume of 36.2M contracts, with revenue of $1.88B (+14.5% YoY). The business model is capital-light with an exceptional ~66% free cash flow margin that is both positive and growing (+12.3% YoY). Approximately 82% of revenue derives from clearing and transaction fees, providing direct leverage to volume growth. CEO Terry Duffy has led the company since 2006 -- a 20+ year tenure -- with an ~83% promise hit rate on forward guidance, representing exceptional management stability and credibility. The monopolistic/near-monopolistic competitive position across multiple asset classes, combined with network effects and cross-margining savings, creates a near-impenetrable moat. All quality gates pass cleanly with zero NOs.

CEOTerry Duffy (since 2006)Market Cap$83.9B
Revenue Mix~82% clearing/transaction feesQ1'26 ADV36.2M contracts (record)
FCF Margin~66%Fiscal Year EndDecember 31
Quality GatePASS (0 NOs)

Quality gate

ALL PASS — Zero NOs. No score cap applied.

Oligopoly position (>30% share)?YES — >50% share in interest rates, equity index, energy (WTI), agriculture, metals. Controls >70% of US exchange-listed derivatives.Positive and growing FCF?YES — ~66% FCF margin, strongly positive and growing +12.3% YoY.
Management 3+ year track record?YES — Terry Duffy has led CME since 2006 (20+ years), ~83% promise hit rate, record ADV in Q1'26.

Score breakdown
9
/ 10
Financial TrendsWeight: 25%
Q1'26 revenue of $1.88B (+14.5% YoY) on record ADV of 36.2M contracts. ~66% FCF margin is exceptional and growing (+12.3% YoY). ~82% of revenue from clearing/transaction fees provides direct volume leverage. Revenue growth is structurally volume-driven, not pricing-dependent, making the growth engine durable and self-reinforcing through network effects.
9
/ 10
Thematic ExposureWeight: 35%
Monopolistic or dominant positions across all core asset classes: >50% share in interest rates, equity indexes, energy (WTI), agriculture, and metals. One of the sole players controlling >70% of US exchange-listed derivatives. Structural tailwinds from rising US debt ($36T+), global risk management needs, crypto expansion, event contracts, and treasury clearing mandate provide multi-year growth vectors.
8
/ 10
Management QualityWeight: 20%
CEO Terry Duffy has led since 2006 (20+ years), delivering an ~83% promise hit rate on forward guidance. Record ADV of 36.2M contracts in Q1'26 reflects consistent operational execution. Capital allocation is disciplined with generous shareholder returns. The 20-year track record of consistent delivery through multiple market cycles is exceptional in financial services.
6
/ 10
Investor Sentiment (Inverted)Weight: 5%
The thesis is well understood by the market -- CME's monopolistic position and capital-light model are consensus-recognized strengths. The investment case is not contrarian; the quality is priced in at current levels. Limited management-vs-street divergence constrains the inverted sentiment score. Under-appreciated optionalities exist but the core thesis lacks the asymmetric information edge that would push this higher.
7
/ 10
Concerns / Catalysts / RisksWeight: 15%
Primary watch items include regulatory/competitive evolution in exchange-listed derivatives, potential volume mean-reversion after consecutive record years, and rate environment normalization that could compress interest rate ADV. The moat is among the widest in financial services -- competitive displacement risk is near zero -- but valuation and cyclical volume sensitivity are ongoing monitoring points.
DimensionScoreWeightWeighted
Financial Trends925%2.25
Thematic Exposure935%3.15
Management Quality820%1.60
Investor Sentiment (Inverted)65%0.30
Concerns / Catalysts / Risks715%1.05
Composite100%8.35

Summary thesis

CME Group scores 8.35/10, reflecting a textbook monopoly/near-monopoly franchise with exceptional financial metrics (9/9 on financials and thematic). Revenue is volume-driven on record ADV of 36.2M contracts in Q1'26, FCF margin is ~66% and growing, and CEO Terry Duffy has a 20+ year track record with an ~83% promise hit rate. All quality gates pass cleanly with zero NOs.

The composite is held from a perfect score by two factors. First, modest sentiment-inversion limitations (6/10): the thesis is well understood by the market -- CME's monopolistic position, capital-light model, and exceptional margins are consensus-recognized strengths, leaving limited room for contrarian edge. Second, regulatory and competitive watch items (7/10): while competitive displacement risk is near zero given the moat, volume cyclicality and rate environment normalization remain ongoing monitoring points.

Key question: With the monopolistic position fully priced in, does the combination of new growth vectors (event contracts, treasury clearing mandate, crypto expansion, 24/7 trading) compound ADV growth above the market's embedded expectations -- or does volume mean-reversion after consecutive record years narrow the upside from here?


What to watch

Key catalysts and monitoring points:


Data sourced from Daloopa and company filings. Analysis date June 24, 2026.